Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice. - Wikidata - awgldk - TriplyDB

Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.

Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.

http://www.wikidata.org/entity/Q48024005

about

Fcγ receptors and ligands and cardiovascular disease The innate immune response to products of phospholipid peroxidation Pentraxins: structure, function, and role in inflammation C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells.Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm Atherosclerosis-related functions of C-reactive protein.Systemic inflammation and early atheroma formation: are they related?Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis Chronic inflammatory muscle diseases and risk of coronary artery disease.Recognition functions of pentameric C-reactive protein in cardiovascular disease Obese hypertensive men have plasma concentrations of C-reactive protein similar to that of obese normotensive men.C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases.

P2860

Q27021449-8439B974-81DB-4B63-B23D-B525C9287707 Q28389385-90F8EA3F-86B7-45A4-A9FA-4BF47C8B48FB Q28676262-4EC30C6C-D3FA-4583-BC8D-D7EF6DEC54E7 Q33562207-D6102D24-3FB3-49C5-A7D8-EED5522B2C94 Q33756098-25A6FCA2-38C8-4EFD-9AE5-25206F9BC6B4 Q35073552-25F4725A-C4F0-495B-97AA-4D81DBA4975D Q35154761-10FD322B-BA8A-4875-8DFF-408678B365E6 Q35728529-F98C7018-8AF0-421E-A88C-90A54DDBA26B Q38076079-7991EE34-3163-4CF6-8C48-B699C0C426A0 Q38221846-19429FB0-9CD6-4321-B32A-627621FBE801 Q46438151-ECC503BF-02F1-43F8-8525-6038E5704612 Q54639844-004461D0-B09E-41B2-BD49-AC3932AC16DE

P2860

Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.

http://www.wikidata.org/entity/Q48024005

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Continuously-infused human C-r ...... olipoprotein E-deficient mice.

@en

Continuously-infused human C-r ...... olipoprotein E-deficient mice.

@nl

type

label

Continuously-infused human C-r ...... olipoprotein E-deficient mice.

@en

Continuously-infused human C-r ...... olipoprotein E-deficient mice.

@nl

prefLabel

Continuously-infused human C-r ...... olipoprotein E-deficient mice.

@en

Continuously-infused human C-r ...... olipoprotein E-deficient mice.

@nl

P1433

Q48024005-458318A2-B364-4E05-A6B2-E2A7610E8311

P1476

Q48024005-013D98AA-7C1C-4882-BEED-DF5BBB3DDCD4

P2093

Q48024005-029D1C78-F97D-4546-B441-44A406CA54AC

Q48024005-394FD591-1996-473F-A730-57758705F9E5

Q48024005-3F441996-0FF5-4CB3-B674-371CBB89C7BA

Q48024005-9A5FD296-1B24-49CB-AF58-11C6EE8DDA91

Q48024005-C282EC4B-B965-45C6-ADB9-17C4D0FDA09E

Q48024005-DB2BFE54-55F4-4006-883C-CAA44F913B36

Q48024005-E75FF6CA-83E4-4CBD-AC8E-F0C6F5A0CD1B

P2860

Q48024005-11BE2258-F128-4A5F-A889-55F6CD9931A9

Q48024005-1765A65A-4AB2-422E-9D8E-097AA653EEB8

Q48024005-214328EB-BCFE-48F0-B733-BD5964D663B4

Q48024005-33DBC9F1-FCAB-4BD8-B313-EF61A47E66A7

Q48024005-4059C27E-0AB3-4A64-AE67-3AB231D984A2

Q48024005-4C92EA78-3579-49F1-861F-75C353319D5F

Q48024005-4D553707-921C-4F3A-8B8D-E1CB5BD600C6

Q48024005-54A1D1C5-F3EB-4719-94BF-3ECC14ACBDEF

Q48024005-613F9AA0-CCE8-4612-8882-3B33A127679A

Q48024005-7FDA0F31-64C6-4B32-8E2D-ACDC663D0F0F

P304

Q48024005-F87718C9-297A-4C01-A523-9DA837FE1557

P31

Q48024005-20732D3C-4362-49A0-BD1A-515DEDF0DC08

P356

Q48024005-B5A440F6-4C94-46CE-9D45-CCA11D8C9A16

P433

Q48024005-88D829D3-454F-4A8A-8F67-5EB7752929FE

P478

Q48024005-057C51CE-887B-4934-AD74-912B6D56D18C

P577

Q48024005-6D842CE8-E289-46BC-BA73-4579A9C6BA28

P5875

Q48024005-47C73C67-BB5F-4558-97FE-03F7F9BC118C

P698

Q48024005-4F18226D-D784-41D2-9167-954C76FA9313

P356

P1433

Experimental Biology and Medicine

P1476

Continuously-infused human C-r ...... olipoprotein E-deficient mice.

@en

P2093

Candace L Walker

http://www.w3.org/2001/XMLSchema#string

Carlos A Labarrere

http://www.w3.org/2001/XMLSchema#string

George Boguslawski

http://www.w3.org/2001/XMLSchema#string

Gonzalo L Campana

http://www.w3.org/2001/XMLSchema#string

John R Woods

http://www.w3.org/2001/XMLSchema#string

Marcelo J Sosa

http://www.w3.org/2001/XMLSchema#string

Miguel A Ortiz

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells

C-reactive protein: a critical update

Inflammation, atherosclerosis, and coronary artery disease

Adhesion molecules and atherogenesis.

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors.

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice.

P304

624-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3181/0812-RM-347

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

234

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24271238

http://www.w3.org/2001/XMLSchema#string

P698

19359657

http://www.w3.org/2001/XMLSchema#string